A novel gene signature for predicting response to chemoradiotherapy in esophageal adenocarcinoma.

445Background: While neoadjuvant chemoradiotherapy (CRT) has emerged as an important treatment modality in patients with locally advanced esophageal adenocarcinoma (EAC), ~60%-70% of patients do no...